scispace - formally typeset
G

Geoffrey A. Rose

Researcher at Harvard University

Publications -  21
Citations -  609

Geoffrey A. Rose is an academic researcher from Harvard University. The author has contributed to research in topics: Appropriate Use Criteria & Dobutamine. The author has an hindex of 11, co-authored 21 publications receiving 557 citations.

Papers
More filters
Journal ArticleDOI

Accurate localization of mitral regurgitant defects using multiplane transesophageal echocardiography.

TL;DR: This transesophageal echocardiographic strategy provides a systematic method to accurately localize mitral Regurgitant lesions and has the potential to improve the preoperative assessment of patients with significant mitral regurgitation.
Journal ArticleDOI

Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy

TL;DR: Coronary endothelial dysfunction exists at both the microvascular and the epicardial level in patients with acute-onset idiopathic DCM and the preservation of coronary endothelial function in this population is associated with subsequent improvement in left ventricular function.
Journal ArticleDOI

ACC 2015 Core Cardiovascular Training Statement (COCATS 4) (Revision of COCATS 3): A Report of the ACC Competency Management Committee

Jonathan L. Halperin, +109 more
TL;DR: The 2017-18 FACC-MACC curriculum vitae will be presented at a special session in Washington, DC on Wednesday, 3 March 2017 to discuss the design and implementation of the curriculum for the 2016-17 school year.
Journal ArticleDOI

COCATS 4 Task Force 5: Training in Echocardiography

TL;DR: The writing committee was selected to represent the American College of Cardiology and American Society of Echocardiography and included a cardiovascular training program director, an echOCardiography expert, and an e-book author.
Journal ArticleDOI

A clinical rule to predict preserved left ventricular ejection fraction in patients after myocardial infarction

TL;DR: This study hypothesized that simple clinical variables could be used to develop a prediction rule to identify patients after myocardial infarction with a high likelihood of having preserved left ventricular systolic function and aimed to restrict assessment of LVEF to those patients most likely to benefit from the resulting information.